-transparent.png){kind=logo}
The precise mechanism of the neoplastic cell growth of adult T cell leukemia (ATL) still remains unclear. In the present study, we have succeeded in serial transplantation of ATL cells from a patient into severe combined immunodeficient (SCID) mice. In this model, we found that only a leukemic cell clone from an ATL patient could be successively transplanted into SCID mice, although it was difficult to maintain leukemic cell clones in vitro, suggesting that the microenvironment provided by SCID mice is suitable for leukemic cell growth. We could not detect human T cell leukemia virus type I (HTLV-I) mRNA or interleukin 2 (IL-2) mRNA in either the tumor cells growing in mice or the original leukemic cells. Thus, it appears that neither HTLV-I viral expression nor the IL-2 autocrine mechanism is directly involved in the neoplastic cell growth of fresh ATL cells as well as HTLV-I-infected cell lines, at least in SCID mice. In addition, we could passage frozen cells and obtain a large number of expanded leukemic cells in this model. Such a serial transplantation model, which can avoid the changes in the nature of leukemic cells that are frequently observed in in vitro culture, and which can propagate leukemic cell clones, would be very suitable not only to study the mechanism of neoplastic cell growth, but also to test potential therapeutic agents for ATL.
K Imada, and
A Takaori-Kondo, and
H Sawada, and
A Imura, and
S Kawamata, and
M Okuma, and
T Uchiyama
August 1993,
Blood,
K Imada, and
A Takaori-Kondo, and
H Sawada, and
A Imura, and
S Kawamata, and
M Okuma, and
T Uchiyama
March 1995,
Journal of neuroimmunology,
K Imada, and
A Takaori-Kondo, and
H Sawada, and
A Imura, and
S Kawamata, and
M Okuma, and
T Uchiyama
April 1997,
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica,
K Imada, and
A Takaori-Kondo, and
H Sawada, and
A Imura, and
S Kawamata, and
M Okuma, and
T Uchiyama
August 1994,
Clinical and experimental immunology,
K Imada, and
A Takaori-Kondo, and
H Sawada, and
A Imura, and
S Kawamata, and
M Okuma, and
T Uchiyama
December 1986,
Tumori,
K Imada, and
A Takaori-Kondo, and
H Sawada, and
A Imura, and
S Kawamata, and
M Okuma, and
T Uchiyama
December 1994,
The Journal of veterinary medical science,
K Imada, and
A Takaori-Kondo, and
H Sawada, and
A Imura, and
S Kawamata, and
M Okuma, and
T Uchiyama
February 1994,
Clinical and experimental immunology,
K Imada, and
A Takaori-Kondo, and
H Sawada, and
A Imura, and
S Kawamata, and
M Okuma, and
T Uchiyama
October 1991,
Experimental hematology,
K Imada, and
A Takaori-Kondo, and
H Sawada, and
A Imura, and
S Kawamata, and
M Okuma, and
T Uchiyama
June 2000,
British journal of haematology,
K Imada, and
A Takaori-Kondo, and
H Sawada, and
A Imura, and
S Kawamata, and
M Okuma, and
T Uchiyama
August 1993,
Blood,
